Method of detaching adherent cells for flow cytometry
US-2015368620-A1 · Dec 24, 2015 · US
US9927427B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9927427-B2 |
| Application number | US-201415031660-A |
| Country | US |
| Kind code | B2 |
| Filing date | Oct 15, 2014 |
| Priority date | Oct 24, 2013 |
| Publication date | Mar 27, 2018 |
| Grant date | Mar 27, 2018 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
A method of isolating exosomes includes conducting at least one purification step in the presence of an organic zwitterion having a molecular weight of less than about 350 Daltons, a buffering pK of a negatively charged portion of the organic zwitterion is at least one full pH unit below an operating pH at which the at least one purification step is conducted, and a buffering pK of the positively charged portion of the organic zwitterion is at least one full pH unit above the operating pH.
Opening claim text (preview).
What is claimed is: 1. A method of isolating exosomes comprising: conducting at least one purification step in the presence of an organic zwitterion having a molecular weight of less than about 350 Daltons, wherein a buffering pK of a negatively charged portion of the organic zwitterion is at least one full pH unit below an operating pH at which the at least one purification step is conducted, and a buffering pK of a positively charged portion of the organic zwitterion is at least one full pH unit above the operating pH, wherein the organic zwitterion is an amino acid or a peptide comprising from 2 to 5 amino acids, the amino acid or peptide amino acids being selected from the group consisting of glycine, alanine, N,N,N-trimethylglycine (betaine), and taurine. 2. The method of claim 1 , wherein a molar dielectric increment of the organic zwitterion under the operating conditions of the at least one purification step is greater than about 17. 3. The method of claim 1 , wherein the at least one organic zwitterion is glycine or alanine. 4. The method of claim 1 , wherein a concentration of the organic zwitterion is from about 20 mM to about 3 M, or saturated. 5. The method of claim 4 , wherein the concentration of the organic zwitterion is selected from the group consisting of (a) from about 5 mM to about 20 mM, (b) from about 20 mM to about 50 mM, (c) from about 50 mM to about 100 mM, (d) from about 100 mM to about 300 mM, (e) from about 300 mM to about 3 M, and (f) saturated. 6. The method of claim 1 , wherein before conducting the at least one purification step, the exosomes are unpurified, partially purified, or purified. 7. The method of claim 1 , wherein an osmolarity during the at least one purification step is in a range from about 250 milliOsmoles/kg to about 300 milliOsmoles/kg. 8. The method of claim 1 , wherein an osmolarity during the at least one purification step is less than 250 milliOsmoles/kg. 9. The method of claim 1 , wherein an osmolarity during the at least one purification step is greater than 300 milliOsmoles/kg. 10. The method of claim 1 , wherein the at least one purification step comprises a filtering step. 11. The method of claim 1 , wherein the at least one purification step comprises a chromatography step. 12. The method of claim 1 , wherein the at least one purification step comprises a field flow fractionation step. 13. The method of claim 1 , wherein the at least one purification step comprises a centrifugation step. 14. The method of claim 11 , wherein the chromatography step comprises a size exclusion chromatography step. 15. The method of claim 14 , wherein the organic zwitterion is glycine or alanine at a concentration of 20 mM to 300 mM. 16. The method of claim 14 , wherein the at least one purification step comprises contacting a sample comprising exosomes with a size exclusion chromatography media in the presence of the organic zwitterion, wherein the organic zwitterion is in a soluble form. 17. The method of claim 16 , wherein the sample, prior to conducting of the at least one purification step, comprises non-exosome proteins, and the method further comprises, after the conducting of the at least one purification step, providing isolated exosomes, wherein the isolated exosomes comprise at least 95% of the exosomes in the sample and less than 5% of the of the non-exosome proteins in the sample. 18. A method of isolating exosomes comprising: conducting at least one purification step in the presence of an organic zwitterion having a molecular weight of less than about 350 Daltons, wherein a buffering pK of a negatively charged portion of the organic zwitterion is at least one full pH unit below an operating pH at which the at least one purification step is conducted, and a buffering pK of a positively charged portion of the organic zwitterion is at least one full pH unit above the operating pH, wherein the at least one purification step comprises a filtering step, a field flow fractionation step, a centrifugation step, or a size exclusion chromatography step. 19. The method of claim 18 , wherein the at least one purification step comprises contacting a sample comprising exosomes with a size exclusion chromatography media in the presence of the organic zwitterion, wherein the organic zwitterion is in a soluble form. 20. The method of claim 18 , wherein the organic zwitterion comprises a positively charged nitrogen group and a negatively charged group distal to the positively charged nitrogen group on the organic zwitterion such that there is a separation by at least one carbon atom. 21. The method of claim 20 , wherein the at least one carbon atom comprises an uncharged side chain.
involving human or animal cells (immunoassay G01N33/56966; immunoassays of protozoa G01N33/56905; protozoa in screening assays C12Q1/025) · CPC title
Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells (vaccines or medicinal preparations containing antigens or antibodies A61K39/00) · CPC title
involving cell organelles, e.g. Golgi complex, endoplasmic reticulum · CPC title
Amphoteric or zwitterionic ion-exchanger · CPC title
Filters adapted for location in special places, e.g. pipe-lines, pumps, stop-cocks, (B01D35/05 takes precedence; {water pipe system filters E03B3/18, E03B7/07; dirt catchers in sewers E03F; filters or strainers for pipe-lines in general B08B, E03F; object or dirt catching devices in sinks or the like E03C1/26; suction strainers or filters for pumps F04B53/005, F04D29/70}) · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.